CoChat

Faecalibacterium prausnitzii Ameliorates Colorectal Tumorigenesis and Suppresses Proliferation of HCT116 Colorectal Cancer Cells

Open access
Dikeocha, Ifeoma Julieth, Al-Kabsi, Abdelkodose Mohammed, Chiu, Hsien-Tai, Alshawsh, Mohammed Abdullah · 2022 · Biomedicines

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Abstract

Faecalibacterium prausnitzii is one of the most abundant commensals of gut microbiota that is not commonly administered as a probiotic supplement. Being one of the gut’s major butyrate-producing bacteria, its clinical significance and uses are on the rise and it has been shown to have anti-inflammatory and gut microbiota-modulating properties in the treatment of inflammatory bowel illness, Crohn’s disease, and colorectal cancer. Colorectal cancer (CRC) is a silent killer disease that has become one of the leading causes of cancer-related death worldwide. This study aimed to evaluate the anti-tumorigenic and antiproliferative role of F. prausnitzii as well as to study its effects on the diversity of gut microbiota in rats. Findings showed that F. prausnitzii probiotic significantly reduced the colonic aberrant crypt foci frequency and formation in Azoxymethane (AOM)-induced CRC in rats. In addition, the administration of F. prausnitzii lowered the lipid peroxidation levels in the colon tissues. For in vitro 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay, the cell-free supernatant of F. prausnitzii suppressed the growth of HCT116 colorectal cancer cells in a time/dose-dependent manner. 16S rRNA gene sequencing using rat stool samples showed that the administration of F. prausnitzii modulated the gut microbiota of the rats and enhanced its diversity. Hence, these findings suggest that F. prausnitzii as a probiotic supplement can be used in CRC prevention and management; however, more studies are warranted to understand its cellular and molecular mechanisms of action.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/biomedicines10051128

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Cell viability of HCT116 colorectal cancer cells. Graphs shows time- and dose-dependent reduction of cell viability of HCT116 cells treated with F. prausnitzii cell-free supernatants (A) and 5-Fluorouracil (B) for 12, 24, 48, and 72 h. All values are expressed as the mean ± SEM of triplicates.
Figure 1 Cell viability of HCT116 colorectal cancer cells. Graphs shows time- and dose-dependent reduction of cell viability of HCT116 cells treated with F. prausnitzii cell-free supernatants (A) and 5-Fluorouracil (B) for 12, 24, 48, and 72 h. All values are expressed as the mean ± SEM of triplicates.CC BY · PubMed Central
Figure 2 Outcomes of the animal experiment. (A) Body weight (gm) of rats in different experimental groups, (B) Total Aberrant crypt foci (ACF) count in the colon of treated and control groups, (C) Percentage inhibition of aberrant crypt foci (ACF) formation in colon of treated and control groups (D) Malondialdehyde (MDA) level in treated and untreated control groups. All values are expressed as the mean ± SEM and were analyzed using one-way ANOVA, *** p < 0.001 indicates a significant difference compared to the AOM group, n = 5 animals per group. (NC): Normal control, (AOM): Azoxymethane, (FP): F. prausnitzii, (5-FU): 5-fluorouracil.
Figure 2 Outcomes of the animal experiment. (A) Body weight (gm) of rats in different experimental groups, (B) Total Aberrant crypt foci (ACF) count in the colon of treated and control groups, (C) Percentage inhibition of aberrant crypt foci (ACF) formation in colon of treated and control groups (D) Malondialdehyde (MDA) level in treated and untreated control groups. All values are expressed as the mean ± SEM and were analyzed using one-way ANOVA, *** p < 0.001 indicates a significant difference compared to the AOM group, n = 5 animals per group. (NC): Normal control, (AOM): Azoxymethane, (FP): F. prausnitzii, (5-FU): 5-fluorouracil.CC BY · PubMed Central
Figure 3 (A) Methylene blue stain shows the aberrant crypt foci (ACF), (scale bar= 200 µm). The arrow points to the abnormal crypts that show ACF lesions (B) Hematoxylin and eosin (H & E) staining findings of the colon of treated and untreated control groups, (scale bar= 50 µm). The orange arrows show enlarged crypts, while the black arrows point to the inflammatory infiltration. (NC): Normal control, (AOM): Azoxymethane, (FP): F. prausnitzii and (5-FU): 5-fluorouracil.
Figure 3 (A) Methylene blue stain shows the aberrant crypt foci (ACF), (scale bar= 200 µm). The arrow points to the abnormal crypts that show ACF lesions (B) Hematoxylin and eosin (H & E) staining findings of the colon of treated and untreated control groups, (scale bar= 50 µm). The orange arrows show enlarged crypts, while the black arrows point to the inflammatory infiltration. (NC): Normal control, (AOM): Azoxymethane, (FP): F. prausnitzii and (5-FU): 5-fluorouracil.CC BY · PubMed Central
Figure 4 Plot of microbial diversity analysis at the phylum level. (NC): Normal control group, (AOM): azoxymethane group, (FP): F. prausnitzii group, (5FU): 5-fluorouracil group.
Figure 4 Plot of microbial diversity analysis at the phylum level. (NC): Normal control group, (AOM): azoxymethane group, (FP): F. prausnitzii group, (5FU): 5-fluorouracil group.CC BY · PubMed Central
Figure 5 Plot of microbial diversity analysis at the genus level. (NC): Normal control group, (AOM): azoxymethane control group, (FP): F. prausnitzii group, (5FU): 5-fluorouracil group.
Figure 5 Plot of microbial diversity analysis at the genus level. (NC): Normal control group, (AOM): azoxymethane control group, (FP): F. prausnitzii group, (5FU): 5-fluorouracil group.CC BY · PubMed Central
Figure 6 Heatmap of microbial diversity analysis at the genus level. (NC): Normal control group, (AOM): azoxymethane control group, (FP): F. prausnitzii group, (5FU): 5-fluorouracil reference group.
Figure 6 Heatmap of microbial diversity analysis at the genus level. (NC): Normal control group, (AOM): azoxymethane control group, (FP): F. prausnitzii group, (5FU): 5-fluorouracil reference group.CC BY · PubMed Central
Figure 7 Rarefaction curve of the Shannon index shown as sequences per sample. The x-axis shows the number of reads per sample, while the y-axis indicates the Shannon index. Each curve represents a different sample and is illustrated in a different color. A lower Shannon index indicates higher diversity while higher values indicate less diversity. The microbiota of the control (NC) samples was significantly less diverse than that in the other groups. (NC): Normal control group, (AOM): azoxymethane control group, (FP): F. prausnitzii group, (5FU): 5-fluorouracil reference group.
Figure 7 Rarefaction curve of the Shannon index shown as sequences per sample. The x-axis shows the number of reads per sample, while the y-axis indicates the Shannon index. Each curve represents a different sample and is illustrated in a different color. A lower Shannon index indicates higher diversity while higher values indicate less diversity. The microbiota of the control (NC) samples was significantly less diverse than that in the other groups. (NC): Normal control group, (AOM): azoxymethane control group, (FP): F. prausnitzii group, (5FU): 5-fluorouracil reference group.CC BY · PubMed Central
Figure 8 The relative abundance (%) of Bacteroidetes (A), (%) Firmicutes (B), and Firmicutes/Bacteroidetes ratio (C) in the treated groups and control. All values are expressed as the mean ± SEM and were analyzed using one-way ANOVA; * p < 0.05, ** p < 0.01, *** p < 0.001 indicate significant difference compared to the AOM group. (NC): Normal control group, (AOM): azoxymethane control group, (FP): F. prausnitzii group, (5FU): 5-fluorouracil reference group.
Figure 8 The relative abundance (%) of Bacteroidetes (A), (%) Firmicutes (B), and Firmicutes/Bacteroidetes ratio (C) in the treated groups and control. All values are expressed as the mean ± SEM and were analyzed using one-way ANOVA; * p < 0.05, ** p < 0.01, *** p < 0.001 indicate significant difference compared to the AOM group. (NC): Normal control group, (AOM): azoxymethane control group, (FP): F. prausnitzii group, (5FU): 5-fluorouracil reference group.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 46 references

Cited by

See all 122

Metadata

Authors
Dikeocha, I. J., Al-Kabsi, A. M., Chiu, H.-T., & Alshawsh, M. A.
Affiliations
  • University of Cyberjaya (MY)
  • Faculty of Medicine, University of Cyberjaya, Persiaran Bestari, Cyberjaya 63000, Malaysia
  • National Cheng Kung University (TW)
  • University of Malaya (MY)
Corresponding author
Alshawsh, Mohammed Abdullah
Venue
Biomedicines
Publisher
MDPI AG
Published
2022-05-13
Volume
10
Issue
5
Pages
1128
ISSN
2227-9059 (ISSN-L)
OpenAlex
W4280562196
Cited by
116
References
46
Citations by year
2026: 33 · 2025: 31 · 2024: 31 · 2023: 18 · 2022: 3
FWCI
6.86
Type
journal article
Language
en
Open access
Locations
  • Biomedicines (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • a research grant from the Universiti Malaya (ST015-2020, CRG/01/02/2020)
  • a research grant from the University of Cyberjaya (ST015-2020, CRG/01/02/2020)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
Keywords
Faecalibacterium prausnitzii, colorectal cancer, colorectal carcinogenesis, HCT116 cells, cell proliferation, gut microbiota diversity, butyrate, aberrant crypt foci, lipid peroxidation, probiotics, cancer prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Faecalibacterium prausnitzii Ameliorates Colorectal Tumorigenesis and Suppresses Proliferation of HCT116 Colorectal Cancer Cells. https://app.cochat.ai/papers/10.3390/biomedicines10051128
The paper
Dikeocha, I. J., Al-Kabsi, A. M., Chiu, H.-T., & Alshawsh, M. A. (2022). Faecalibacterium prausnitzii Ameliorates Colorectal Tumorigenesis and Suppresses Proliferation of HCT116 Colorectal Cancer Cells. Biomedicines. https://doi.org/10.3390/biomedicines10051128

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.